⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10889799 | 0.80 | ESR1 (0.50) | — | |
| SCHEMBL437592 | 0.67 | TP53 (0.50) | — | |
| SCHEMBL116879 | 0.67 | ALDH1A1 (0.44) | — | |
| SCHEMBL521745 | 0.67 | — | — | |
| SCHEMBL82309 | 0.67 | — | — | |
| SCHEMBL2011066 | 0.67 | — | — | |
| SCHEMBL629361 | 0.67 | — | — | |
| SCHEMBL3405485 | 0.67 | — | — | |
| SCHEMBL22074011 | 0.67 | — | — | |
| SCHEMBL2366245 | 0.65 | POLB (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111251-A1 | COMPOUNDS THAT INHIBIT POLO-LIKE KINASE 4 | EXELIXIS, INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| CN-116710443-A | 2-pyridones as thyroid hormone receptor modulators | 阿利戈斯治疗公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-116283941-A | Dianhydride compound and polyimide synthesized by same | 深圳先进电子材料国际创新研究院 | 2023-06-23 | — | — | CN | disclosed |
| CN-113698388-A | 6-oxo-1, 6-dihydropyridine derivatives, preparation method and application thereof in medicines | 江苏恒瑞医药股份有限公司 | 2021-11-26 | — | — | CN | disclosed |
| CN-113009122-A | Methods and systems for determining risk of autism spectrum disorders | 美国控股实验室公司 | 2021-06-22 | — | — | CN | disclosed |
| CN-109721529-B | Simple preparation method of 2, 5-dichloropyridine | 新发药业有限公司 | 2020-09-01 | — | — | CN | disclosed |
| US-20140024583-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2014-01-23 | — | — | US | disclosed |
| US-8501746-B2 | Organic compounds | XENON PHARMACEUTICALS INC. (CA) | 2013-08-06 | — | — | US | disclosed |
| WO-2007143597-A9 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-11-11 | — | — | WO | disclosed |
| EP-2029572-B1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-11-03 | — | — | EP | disclosed |
| US-20090156615-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2009-06-18 | — | — | US | disclosed |
| US-6153627-A | Chroman derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2000-11-28 | — | — | US | disclosed |
| US-6040308-A | Chroman derivatives | MERCK GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2000-03-21 | — | — | US | disclosed |
| US-5387587-A | Chroman derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1995-02-07 | — | — | US | disclosed |
| US-4975538-A | MICROBIOCIDES AND BETA-LACTAMASE INHIBITORS | THE UPJOHN COMPANY (US) | 1990-12-04 | — | — | US | disclosed |
| EP-0352269-A1 | ANTIBIOTIC SULFONYLAMINOCARBONYL ACTIVATED $g(b)-LACTAMS | THE UPJOHN COMPANY (US) | 1990-01-31 | — | — | EP | disclosed |
| EP-0281289-A1 | Antibiotic sulfonylaminocarbonyl activated beta-lactams | THE UPJOHN COMPANY (US) | 1988-09-07 | — | — | EP | disclosed |
| WO-1988006588-A1 | ANTIBIOTIC SULFONYLAMINOCARBONYL ACTIVATED beta-LACTAMS | THE UPJOHN COMPANY (US) | 1988-09-07 | — | — | WO | disclosed |